TradeInsight.info
Trade Insight
By Trade
Congress Trade
Insider Trade
Latest Trade
By Insider
Congress Members
Corporate Insiders
More
Features
Pricing
Toggle Sidebar
TradeInsight.info
By Trade
By Insider
Features
Pricing
Search...
⌘
K
Sign In
Try for Free
Previous
1/2
Next
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our
Terms of Service
and
Privacy Policy
.
Email
Password
Forgot your password?
Login
Trade Date*
Filing Date*
Insider Name
Buy/Sell
Company Name
Ticker
Price*
Amount
Shares Change
May 15, 2025
May 19, 2025
Cormorant Asset Management, LP
Former 10% Owner
Sell
Onkure Therapeutics, Inc.
OKUR
$1.85
$3M
-0
May 12, 2025
May 14, 2025
Cormorant Asset Management, LP
10%
Sell
Onkure Therapeutics, Inc.
OKUR
$1.99
$48,236
-1.32%
Feb 14, 2025
Feb 19, 2025
Cormorant Asset Management, LP
Former 10% Owner
Buy
Aardvark Therapeutics, Inc.
AARD
$16
$3M
+15.95%
Nov 04, 2024
Nov 06, 2024
Cormorant Asset Management, LP
10%
Buy
Bright Minds Biosciences Inc.
DRUG
$21.7
$4M
+14.82%
Oct 15, 2024
Oct 17, 2024
Cormorant Asset Management, LP
10%
Buy
Bright Minds Biosciences Inc.
DRUG
$7.65
$3M
+32.57%
Sep 27, 2024
Oct 01, 2024
Cormorant Asset Management, LP
Former 10% Owner
Buy
Bioage Labs, Inc.
BIOA
$18
$8M
+21.64%
Sep 20, 2024
Sep 24, 2024
Cormorant Asset Management, LP
10%
Buy
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$20.01
$7M
+12.84%
May 06, 2024
May 08, 2024
Cormorant Asset Management, LP
10%
Buy
Eyepoint Pharmaceuticals, Inc.
EYPT
$11.86
$10M
+9.26%
Apr 18, 2024
Apr 22, 2024
Cormorant Asset Management, LP
10%
Buy
Eyepoint Pharmaceuticals, Inc.
EYPT
$18.03
$10M
+7.22%
Apr 01, 2024
Apr 03, 2024
Cormorant Asset Management, LP
10%
Sell
Immuneering Corp
IMRX
$2.9
$1M
-12.14%
Mar 14, 2024
Mar 18, 2024
Cormorant Asset Management, LP
10%
Sell
Immuneering Corp
IMRX
$3.02
$3M
-21.62%
Mar 07, 2024
Mar 11, 2024
Cormorant Asset Management, LP
10%
Buy
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$42.41
$23M
+21.36%
Feb 02, 2024
Feb 06, 2024
Cormorant Asset Management, LP
10%
Buy
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$19
$14M
+33.71%
Jan 26, 2024
Jan 30, 2024
Cormorant Asset Management, LP
10%
Buy
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$32.24
$9M
+28.05%
Jan 09, 2024
Jan 11, 2024
Cormorant Asset Management, LP
10%
Buy
Eyepoint Pharmaceuticals, Inc.
EYPT
$19.94
$17M
+11.03%
Dec 08, 2023
Dec 12, 2023
Cormorant Asset Management, LP
10%
Buy
Eyepoint Pharmaceuticals, Inc.
EYPT
$17
$10M
+8.88%
Dec 04, 2023
Dec 06, 2023
Cormorant Asset Management, LP
10%
Buy
Eyepoint Pharmaceuticals, Inc.
EYPT
$21.82
$42M
+26.04%
Oct 23, 2023
Oct 25, 2023
Cormorant Asset Management, LP
10%
Buy
Ambrx Biopharma, Inc.
AMAM
$6.99
$9M
+10.43%
Sep 15, 2023
Sep 19, 2023
Cormorant Asset Management, LP
10%
Buy
Ambrx Biopharma Inc.
AMAM
$9.12
$20M
+3.01%
Jul 20, 2023
Jul 24, 2023
Cormorant Asset Management, LP
(See below)
Sell
Greenlight Biosciences Holdings, Pbc
GRNA
~
$0
-0
Apr 18, 2023
Apr 20, 2023
Cormorant Asset Management, LP
10%
Buy
Ambrx Biopharma Inc.
AMAM
$11.3
$59M
+7.19%
Apr 13, 2023
Apr 17, 2023
Cormorant Asset Management, LP
10%
Buy
Ambrx Biopharma Inc.
AMAM
$9.75
$25M
+4.02%
Mar 14, 2023
Mar 16, 2023
Cormorant Asset Management, LP
10%
Buy
Ambrx Biopharma Inc.
AMAM
$10.21
$10M
+1.83%
Oct 25, 2021
Oct 27, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Ventyx Biosciences, Inc.
VTYX
$16
$10M
+30.71%
Oct 13, 2021
Oct 15, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Pyxis Oncology, Inc.
PYXS
$16
$7M
+28.68%
Sep 17, 2021
Sep 21, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Tyra Biosciences, Inc.
TYRA
$16
$5M
+22.61%
Aug 03, 2021
Aug 05, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Immuneering Corp
IMRX
$15
$8M
+19.62%
Jul 02, 2021
Jul 07, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Aerovate Therapeutics, Inc.
AVTE
$14
$7M
+19.76%
Jun 29, 2021
Jul 01, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Elevation Oncology, Inc.
ELEV
$16
$4M
+10.07%
Jun 28, 2021
Jun 30, 2021
Cormorant Asset Management, LP
Former 10% Owner
Buy
Monte Rosa Therapeutics, Inc.
GLUE
$19
$11M
+15.78%